img

Global Rabies Antiserum Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rabies Antiserum Market Insights, Forecast to 2034

Rabies antiserum is a biological product derived from animal serum used as passive immunity against the rabies virus.
Global Rabies Antiserum market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rabies Antiserum industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The market for rabies antiserum is driven by its applications in the treatment of rabies exposure and prophylaxis. Rabies antiserum provides immediate protection against the virus while the body's immune system responds to the rabies vaccine. As rabies remains a significant public health concern in some regions, the demand for rabies antiserum is expected to continue.
Report Covers
This report presents an overview of global Rabies Antiserum market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rabies Antiserum market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other

Segment by Application


Category II Exposure
Category III Exposure

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rabies Antiserum plant distribution, commercial date of Rabies Antiserum, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rabies Antiserum introduction, etc. Rabies Antiserum Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rabies Antiserum
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rabies Antiserum Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Antiserum Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market by Application
1.3.1 Global Rabies Antiserum Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rabies Antiserum Sales Estimates and Forecasts 2018-2029
2.2 Global Rabies Antiserum Revenue by Region
2.2.1 Global Rabies Antiserum Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rabies Antiserum Revenue by Region (2018-2024)
2.2.3 Global Rabies Antiserum Revenue by Region (2024-2029)
2.2.4 Global Rabies Antiserum Revenue Market Share by Region (2018-2029)
2.3 Global Rabies Antiserum Sales Estimates and Forecasts 2018-2029
2.4 Global Rabies Antiserum Sales by Region
2.4.1 Global Rabies Antiserum Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rabies Antiserum Sales by Region (2018-2024)
2.4.3 Global Rabies Antiserum Sales by Region (2024-2029)
2.4.4 Global Rabies Antiserum Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rabies Antiserum Sales by Manufacturers
3.1.1 Global Rabies Antiserum Sales by Manufacturers (2018-2024)
3.1.2 Global Rabies Antiserum Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Antiserum in 2022
3.2 Global Rabies Antiserum Revenue by Manufacturers
3.2.1 Global Rabies Antiserum Revenue by Manufacturers (2018-2024)
3.2.2 Global Rabies Antiserum Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Antiserum Revenue in 2022
3.3 Global Key Players of Rabies Antiserum, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rabies Antiserum Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rabies Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rabies Antiserum, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rabies Antiserum, Product Offered and Application
3.8 Global Key Manufacturers of Rabies Antiserum, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Antiserum Sales by Type
4.1.1 Global Rabies Antiserum Historical Sales by Type (2018-2024)
4.1.2 Global Rabies Antiserum Forecasted Sales by Type (2024-2029)
4.1.3 Global Rabies Antiserum Sales Market Share by Type (2018-2029)
4.2 Global Rabies Antiserum Revenue by Type
4.2.1 Global Rabies Antiserum Historical Revenue by Type (2018-2024)
4.2.2 Global Rabies Antiserum Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rabies Antiserum Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Antiserum Price by Type
4.3.1 Global Rabies Antiserum Price by Type (2018-2024)
4.3.2 Global Rabies Antiserum Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rabies Antiserum Sales by Application
5.1.1 Global Rabies Antiserum Historical Sales by Application (2018-2024)
5.1.2 Global Rabies Antiserum Forecasted Sales by Application (2024-2029)
5.1.3 Global Rabies Antiserum Sales Market Share by Application (2018-2029)
5.2 Global Rabies Antiserum Revenue by Application
5.2.1 Global Rabies Antiserum Historical Revenue by Application (2018-2024)
5.2.2 Global Rabies Antiserum Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rabies Antiserum Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Antiserum Price by Application
5.3.1 Global Rabies Antiserum Price by Application (2018-2024)
5.3.2 Global Rabies Antiserum Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rabies Antiserum Market Size by Type
6.1.1 US & Canada Rabies Antiserum Sales by Type (2018-2029)
6.1.2 US & Canada Rabies Antiserum Revenue by Type (2018-2029)
6.2 US & Canada Rabies Antiserum Market Size by Application
6.2.1 US & Canada Rabies Antiserum Sales by Application (2018-2029)
6.2.2 US & Canada Rabies Antiserum Revenue by Application (2018-2029)
6.3 US & Canada Rabies Antiserum Market Size by Country
6.3.1 US & Canada Rabies Antiserum Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rabies Antiserum Sales by Country (2018-2029)
6.3.3 US & Canada Rabies Antiserum Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rabies Antiserum Market Size by Type
7.1.1 Europe Rabies Antiserum Sales by Type (2018-2029)
7.1.2 Europe Rabies Antiserum Revenue by Type (2018-2029)
7.2 Europe Rabies Antiserum Market Size by Application
7.2.1 Europe Rabies Antiserum Sales by Application (2018-2029)
7.2.2 Europe Rabies Antiserum Revenue by Application (2018-2029)
7.3 Europe Rabies Antiserum Market Size by Country
7.3.1 Europe Rabies Antiserum Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rabies Antiserum Sales by Country (2018-2029)
7.3.3 Europe Rabies Antiserum Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rabies Antiserum Market Size
8.1.1 China Rabies Antiserum Sales (2018-2029)
8.1.2 China Rabies Antiserum Revenue (2018-2029)
8.2 China Rabies Antiserum Market Size by Application
8.2.1 China Rabies Antiserum Sales by Application (2018-2029)
8.2.2 China Rabies Antiserum Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rabies Antiserum Market Size by Type
9.1.1 Asia Rabies Antiserum Sales by Type (2018-2029)
9.1.2 Asia Rabies Antiserum Revenue by Type (2018-2029)
9.2 Asia Rabies Antiserum Market Size by Application
9.2.1 Asia Rabies Antiserum Sales by Application (2018-2029)
9.2.2 Asia Rabies Antiserum Revenue by Application (2018-2029)
9.3 Asia Rabies Antiserum Sales by Region
9.3.1 Asia Rabies Antiserum Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rabies Antiserum Revenue by Region (2018-2029)
9.3.3 Asia Rabies Antiserum Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rabies Antiserum Market Size by Type
10.1.1 Middle East, Africa and Latin America Rabies Antiserum Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rabies Antiserum Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rabies Antiserum Market Size by Application
10.2.1 Middle East, Africa and Latin America Rabies Antiserum Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rabies Antiserum Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rabies Antiserum Sales by Country
10.3.1 Middle East, Africa and Latin America Rabies Antiserum Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rabies Antiserum Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rabies Antiserum Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Serum China
11.1.1 Serum China Company Information
11.1.2 Serum China Overview
11.1.3 Serum China Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Serum China Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Company Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Lanzhou Institute of Biological Products Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Company Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Wuhan Institute of Biological Products Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Company Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Premium Serums Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Company Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Haffkine Bio-Pharmaceutical Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Company Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Rabies Antiserum Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bharat Serums Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Serums Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Antiserum Industry Chain Analysis
12.2 Rabies Antiserum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Antiserum Production Mode & Process
12.4 Rabies Antiserum Sales and Marketing
12.4.1 Rabies Antiserum Sales Channels
12.4.2 Rabies Antiserum Distributors
12.5 Rabies Antiserum Customers
13 Market Dynamics
13.1 Rabies Antiserum Industry Trends
13.2 Rabies Antiserum Market Drivers
13.3 Rabies Antiserum Market Challenges
13.4 Rabies Antiserum Market Restraints
14 Key Findings in The Global Rabies Antiserum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rabies Antiserum Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 1500IU
Table 3. Major Manufacturers of 1000IU
Table 4. Major Manufacturers of 400IU
Table 5. Major Manufacturers of Other
Table 6. Global Rabies Antiserum Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Rabies Antiserum Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Rabies Antiserum Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Rabies Antiserum Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Rabies Antiserum Revenue Market Share by Region (2018-2024)
Table 11. Global Rabies Antiserum Revenue Market Share by Region (2024-2029)
Table 12. Global Rabies Antiserum Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Rabies Antiserum Sales by Region (2018-2024) & (Kiloton)
Table 14. Global Rabies Antiserum Sales by Region (2024-2029) & (Kiloton)
Table 15. Global Rabies Antiserum Sales Market Share by Region (2018-2024)
Table 16. Global Rabies Antiserum Sales Market Share by Region (2024-2029)
Table 17. Global Rabies Antiserum Sales by Manufacturers (2018-2024) & (Kiloton)
Table 18. Global Rabies Antiserum Sales Share by Manufacturers (2018-2024)
Table 19. Global Rabies Antiserum Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Rabies Antiserum Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Rabies Antiserum, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Rabies Antiserum Price by Manufacturers 2018-2024 (US$/Ton)
Table 23. Global Rabies Antiserum Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Rabies Antiserum by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Antiserum as of 2022)
Table 25. Global Key Manufacturers of Rabies Antiserum, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Rabies Antiserum, Product Offered and Application
Table 27. Global Key Manufacturers of Rabies Antiserum, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 30. Global Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 31. Global Rabies Antiserum Sales Share by Type (2018-2024)
Table 32. Global Rabies Antiserum Sales Share by Type (2024-2029)
Table 33. Global Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Rabies Antiserum Revenue Share by Type (2018-2024)
Table 36. Global Rabies Antiserum Revenue Share by Type (2024-2029)
Table 37. Rabies Antiserum Price by Type (2018-2024) & (US$/Ton)
Table 38. Global Rabies Antiserum Price Forecast by Type (2024-2029) & (US$/Ton)
Table 39. Global Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 40. Global Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 41. Global Rabies Antiserum Sales Share by Application (2018-2024)
Table 42. Global Rabies Antiserum Sales Share by Application (2024-2029)
Table 43. Global Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Rabies Antiserum Revenue Share by Application (2018-2024)
Table 46. Global Rabies Antiserum Revenue Share by Application (2024-2029)
Table 47. Rabies Antiserum Price by Application (2018-2024) & (US$/Ton)
Table 48. Global Rabies Antiserum Price Forecast by Application (2024-2029) & (US$/Ton)
Table 49. US & Canada Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 50. US & Canada Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 51. US & Canada Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 54. US & Canada Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 55. US & Canada Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Rabies Antiserum Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Rabies Antiserum Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Rabies Antiserum Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Rabies Antiserum Sales by Country (2018-2024) & (Kiloton)
Table 61. US & Canada Rabies Antiserum Sales by Country (2024-2029) & (Kiloton)
Table 62. Europe Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 63. Europe Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 64. Europe Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 67. Europe Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 68. Europe Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Rabies Antiserum Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Rabies Antiserum Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Rabies Antiserum Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Rabies Antiserum Sales by Country (2018-2024) & (Kiloton)
Table 74. Europe Rabies Antiserum Sales by Country (2024-2029) & (Kiloton)
Table 75. China Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 76. China Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 77. China Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 80. China Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 81. China Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 84. Asia Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 85. Asia Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 88. Asia Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 89. Asia Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Rabies Antiserum Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Rabies Antiserum Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Rabies Antiserum Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Rabies Antiserum Sales by Region (2018-2024) & (Kiloton)
Table 95. Asia Rabies Antiserum Sales by Region (2024-2029) & (Kiloton)
Table 96. Middle East, Africa and Latin America Rabies Antiserum Sales by Type (2018-2024) & (Kiloton)
Table 97. Middle East, Africa and Latin America Rabies Antiserum Sales by Type (2024-2029) & (Kiloton)
Table 98. Middle East, Africa and Latin America Rabies Antiserum Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Rabies Antiserum Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Rabies Antiserum Sales by Application (2018-2024) & (Kiloton)
Table 101. Middle East, Africa and Latin America Rabies Antiserum Sales by Application (2024-2029) & (Kiloton)
Table 102. Middle East, Africa and Latin America Rabies Antiserum Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Rabies Antiserum Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rabies Antiserum Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Rabies Antiserum Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Rabies Antiserum Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Rabies Antiserum Sales by Country (2018-2024) & (Kiloton)
Table 108. Middle East, Africa and Latin America Rabies Antiserum Sales by Country (2024-2029) & (Kiloton)
Table 109. Serum China Company Information
Table 110. Serum China Description and Major Businesses
Table 111. Serum China Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 112. Serum China Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Serum China Recent Developments
Table 114. Lanzhou Institute of Biological Products Company Information
Table 115. Lanzhou Institute of Biological Products Description and Major Businesses
Table 116. Lanzhou Institute of Biological Products Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 117. Lanzhou Institute of Biological Products Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Lanzhou Institute of Biological Products Recent Developments
Table 119. Wuhan Institute of Biological Products Company Information
Table 120. Wuhan Institute of Biological Products Description and Major Businesses
Table 121. Wuhan Institute of Biological Products Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 122. Wuhan Institute of Biological Products Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Wuhan Institute of Biological Products Recent Developments
Table 124. Premium Serums Company Information
Table 125. Premium Serums Description and Major Businesses
Table 126. Premium Serums Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 127. Premium Serums Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Premium Serums Recent Developments
Table 129. Haffkine Bio-Pharmaceutical Company Information
Table 130. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 131. Haffkine Bio-Pharmaceutical Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 132. Haffkine Bio-Pharmaceutical Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Haffkine Bio-Pharmaceutical Recent Developments
Table 134. Bharat Serums Company Information
Table 135. Bharat Serums Description and Major Businesses
Table 136. Bharat Serums Rabies Antiserum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 137. Bharat Serums Rabies Antiserum Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Bharat Serums Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Rabies Antiserum Distributors List
Table 142. Rabies Antiserum Customers List
Table 143. Rabies Antiserum Market Trends
Table 144. Rabies Antiserum Market Drivers
Table 145. Rabies Antiserum Market Challenges
Table 146. Rabies Antiserum Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Antiserum Product Picture
Figure 2. Global Rabies Antiserum Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rabies Antiserum Market Share by Type in 2022 & 2029
Figure 4. 1500IU Product Picture
Figure 5. 1000IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Other Product Picture
Figure 8. Global Rabies Antiserum Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Rabies Antiserum Market Share by Application in 2022 & 2029
Figure 10. Category II Exposure
Figure 11. Category III Exposure
Figure 12. Rabies Antiserum Report Years Considered
Figure 13. Global Rabies Antiserum Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Rabies Antiserum Revenue 2018-2029 (US$ Million)
Figure 15. Global Rabies Antiserum Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Rabies Antiserum Revenue Market Share by Region (2018-2029)
Figure 17. Global Rabies Antiserum Sales 2018-2029 ((Kiloton)
Figure 18. Global Rabies Antiserum Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Rabies Antiserum Sales YoY (2018-2029) & (Kiloton)
Figure 20. US & Canada Rabies Antiserum Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Rabies Antiserum Sales YoY (2018-2029) & (Kiloton)
Figure 22. Europe Rabies Antiserum Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Rabies Antiserum Sales YoY (2018-2029) & (Kiloton)
Figure 24. China Rabies Antiserum Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Rabies Antiserum Sales YoY (2018-2029) & (Kiloton)
Figure 26. Asia (excluding China) Rabies Antiserum Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Rabies Antiserum Sales YoY (2018-2029) & (Kiloton)
Figure 28. Middle East, Africa and Latin America Rabies Antiserum Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Rabies Antiserum Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Rabies Antiserum in the World: Market Share by Rabies Antiserum Revenue in 2022
Figure 31. Global Rabies Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 33. Global Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 34. Global Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 35. Global Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Rabies Antiserum Revenue Share by Country (2018-2029)
Figure 41. US & Canada Rabies Antiserum Sales Share by Country (2018-2029)
Figure 42. U.S. Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 45. Europe Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 46. Europe Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 47. Europe Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 48. Europe Rabies Antiserum Revenue Share by Country (2018-2029)
Figure 49. Europe Rabies Antiserum Sales Share by Country (2018-2029)
Figure 50. Germany Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 51. France Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 55. China Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 56. China Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 57. China Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 58. China Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 59. Asia Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 60. Asia Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 61. Asia Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 62. Asia Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 63. Asia Rabies Antiserum Revenue Share by Region (2018-2029)
Figure 64. Asia Rabies Antiserum Sales Share by Region (2018-2029)
Figure 65. Japan Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 69. India Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Rabies Antiserum Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Rabies Antiserum Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Rabies Antiserum Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Rabies Antiserum Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Rabies Antiserum Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Rabies Antiserum Sales Share by Country (2018-2029)
Figure 76. Brazil Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Rabies Antiserum Revenue (2018-2029) & (US$ Million)
Figure 81. Rabies Antiserum Value Chain
Figure 82. Rabies Antiserum Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries